BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2022 1:37:25 PM | Browse: 231 | Download: 394
Publication Name World Journal of Gastroenterology
Manuscript ID 78409
Country/Territory United States
Received
2022-06-24 19:29
Peer-Review Started
2022-06-24 19:32
To Make the First Decision
Return for Revision
2022-07-11 23:10
Revised
2022-07-26 01:12
Second Decision
2022-08-22 03:07
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-08-25 19:55
Articles in Press
2022-08-25 19:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-09-06 13:04
Publish the Manuscript Online
2022-09-15 13:37
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis
Manuscript Source Invited Manuscript
All Author List Jaspreet Suri, Sebastian Borja and Joseph K Lim
ORCID
Author(s) ORCID Number
Jaspreet Suri http://orcid.org/0000-0002-3897-7234
Joseph K Lim http://orcid.org/0000-0003-1037-5773
Funding Agency and Grant Number
Corresponding Author Joseph K Lim, MD, Professor, Section of Digestive Diseases, Yale University School of Medicine, Yale Liver Center, 333 Cedar Street, LMP 1080, New Haven, CT 06520, United States. joseph.lim@yale.edu
Key Words Non-alcoholic steatohepatitis; Fatty liver; Combination treatment; Drug therapy; Pharmacologic treatment; Clinical trials
Core Tip Multimodal combination approaches targeting two or more molecular pathways contributing to steatohepatitis and liver fibrosis are needed to augment efficacy of novel investigational drug regimens to achieve non-alcoholic steatohepatitis (NASH) resolution and NASH fibrosis improvement.
Publish Date 2022-09-15 13:37
Citation Suri J, Borja S, Lim JK. Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis. World J Gastroenterol 2022; 28(35): 5129-5140
URL https://www.wjgnet.com/1007-9327/full/v28/i35/5129.htm
DOI https://dx.doi.org/10.3748/wjg.v28.i35.5129
Full Article (PDF) WJG-28-5129.pdf
Full Article (Word) WJG-28-5129.docx
Manuscript File 78409_Auto_Edited-LS.docx
Answering Reviewers 78409-Answering reviewers.pdf
Audio Core Tip 78409-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 78409-Conflict-of-interest statement.pdf
Copyright License Agreement 78409-Copyright license agreement.pdf
Peer-review Report 78409-Peer-review(s).pdf
Scientific Misconduct Check 78409-Bing-Fan JR-2.png
Scientific Editor Work List 78409-Scientific editor work list.pdf